Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial

Oct. 15, 2010

GAA peptide-loaded DC1-based vaccine shows promise in recurrent malignant glioma

Oct. 15, 2010

IPI-926 is well tolerated and active in patients with solid tumors

Oct. 15, 2010

Pritumumab is active in patients with brain cancer

Oct. 15, 2010

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Oct. 14, 2010

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Oct. 14, 2010

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Oct. 14, 2010

PBT-434 prevents nigral cell death in models of Parkinson's disease

Oct. 14, 2010

Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence

Oct. 13, 2010

Pfizer introduces new candidates for inhalation therapy of COPD

Oct. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...